Breast Cancer Now Annual Report 2015/2016

We’re determined to stop women dying from breast cancer. We know it can be done. But it’s only by standing together – as scientists, policy makers, fundraisers, families, colleagues and campaigners – that we will make it happen.

Our Annual Report and Accounts 2015/16 demonstrate that by uniting, as a family, we are making a positive impact across the UK for people affected by breast cancer.

Breast Cancer Now Annual Report 2015/2016

2014/2015 Annual Report

Breast Cancer Now - the UK’s largest breast cancer charity dedicated to funding world-class research - was created by the merger of Breast Cancer Campaign and Breakthrough Breast Cancer.

For more than 25 years as separate charities, we were committed to funding the very best in breast cancer research across prevention, diagnosis, treatments and secondary breast cancer. Our ambition was simple, and it was shared: to find a way to stop women dying from breast cancer.

Our Annual Report represents an amalgamation of results – the legacy charities results up to the 31 March 2015 plus the results of the combined charity, Breast Cancer Now, from 1 April to 31 July 2015.


Legacy charity accounts

Download the annual report and accounts for Breast Cancer Campaign and Breakthrough Breast Cancer, the two charities that merged in June 2015 to form Breast Cancer Now.

Breast Cancer Campaign annual reports

Breakthrough Breast Cancer annual reports

Pharmaceutical donations 2013 - 2015

Download the figures

The Breast Cancer Now Catalyst Programme

The Breast Cancer Now Catalyst Programme, is an initiative which aims to bring together Europe’s leading breast cancer researchers and the world’s leading pharmaceutical companies to pool resources and stop women dying from breast cancer by 2050. The first collaborator signed up to the Catalyst Programme is the biopharmaceutical company Pfizer. Pfizer has committed $15m USD (around £10m) over three years, which opens an exciting opportunity for breast cancer research.

The programme aims to enable Europe’s leading researchers to design independently selected research programmes, using companies’ existing breast cancer drugs or  molecules that they’re still working on in their laboratories. We aim to speed up the translation of research into new more effective targeted treatments and therapies for breast cancer patients. Find out more about the Breast Cancer Now Catalyst Programme.

More information

Please contact our Supporter Engagement team with any questions by emailing or calling 0333 20 70 300.